ALPMY Dividends Insights

ALPMY pays dividends semiannually. Last paid amount was $0.214 at Mar 31, 2026. As of today, dividend yield (TTM) is 5.11%.

Dividend Score Premium

Avoid dividend cuts
with our Dividend Score

Start 7-Day Free Trial

Safety Rating

AI Analysis AI Analysis of ALPMY
AI-Powered Dividend Insights

Built on AI-powered analysis of yield strength, recent news, payout trends, and 10-year dividend growth consistency.

Dividend Yield Range

The Dividend Yield Range is the range of values in which a stock’s dividend yield has fluctuated within a specified period, often a year. It represents the variation between the highest and lowest dividend yields observed during that time frame.
AI Analysis AI Analysis of ALPMY
AI-Powered Market Insights
New!
Dividend Analysis

Key Stats

Dividend Yield (TTM) 5.11%
Frequency Semiannually
1Y Growth -5.06%
Payout Ratio 0
Amount Per Share $0.214
Next Ex-Dividend Date Mar 30, 2026
Next Payment Date Jun 03, 2026

ALPMY Dividend Payout History

To ensure a understanding of ALPMY's dividend performance, consider examining the historical payout ratios and how they align with the company's earnings. Fluctuations in payout amounts may reflect changes in the company's dividend policy or earnings stability.


# Declaration Date Ex-Date Pay Date Amount Yield
51 Mar 29, 2010 Mar 29, 2010 Jul 12, 2010 $0.182 0%
52 Sep 28, 2009 Sep 28, 2009 Dec 16, 2009 $0.173 0%
53 Mar 29, 2009 Mar 29, 2009 Jul 09, 2009 $0.157 0%
Requires Login
Login

Dividend Sustainability

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Its Dividend Growth Potential Score (DGPS) is moderate, indicating limited growth potential. Overall, the dividend outlook is mixed, and merits close monitoring of both financial strength and growth prospects.

DSS - Sustainability score

Good (74.89%)

DSGP - Growth potential

Stable (19.69%)

ALPMY Dividend Calculator

Dividend Calculator is designed to forecast the potential returns from ALPMY dividends based on your individual investment size or the number of shares you own. Simply enter your total investment amount to see the cumulative dividend payment you could receive over a specified period.
Read how to invest in ALPMY stock here.

Comparing ALPMY to Sector and Country

ALPMY pays a solid dividend yield of 5.11%, which is higher than the average of the bottom 25% of dividend payers in the US market (0.560%). ALPMY’s dividend yield is lower than the average of the top 25% of dividend payers in the Healthcare sector in the US market (8.73%), which means that there are more attractive dividend stocks to consider.

FAQ

What factors can affect the amount of ALPMY's dividend payments?
The amount of ALPMY's dividends can fluctuate based on several factors, including the company's financial performance, earnings, cash flow, capital requirements, and overall market conditions. Changes in ALPMY sector's trends, interest rate shifts, and the company's operational adjustments can also influence dividend decisions.

Can dividends from ALPMY stock be automatically reinvested?
If ALPMY offers a Dividend Reinvestment Plan (DRIP), shareholders may have the option to automatically reinvest dividends to purchase additional shares. Please check with your brokerage for the availability and details of such a plan. Here's an easy guide on how to buy ALPMY stock.

How often does ALPMY pay dividend?
ASTELLAS PHARMA INC (ALPMY) pays dividends semiannually. The most recent payout was on Mar 31, 2026. The upcoming dividend Ex Date is Mar 30, 2026, with an amount of $0.244.

How much does ALPMY pays per share?
The last recorder (Mar 31, 2026) dividend per share was $0.214.

What is ALPMY dividend growth rate?
Over the last year, ASTELLAS PHARMA INC has witnessed growth rate of -5.06% . Looking back over the past 3 years, this growth rate has been 8.53%. Furthermore, examining the past 5 years, ASTELLAS PHARMA INC has maintained an average Dividends Per Share Growth Rate of -0.553%.
Click to get the best stock tips daily for free!
ABOUT ASTELLAS PHARMA INC
ASTELLAS PHARMA
Astellas Pharma Inc. engages in the manufacture, marketing, import, and export of pharmaceuticals worldwide. It provides XTANDI, an androgen receptor signaling inhibitor for prostate cancer; XOSPATA, a FLT3 inhibitor for adult patients with relapsed or refractory acute myeloid leukemia with a FLT3 mutation-positive; PADCEV, a treatment solution for adult patients with locally advanced or metastatic urothelial cancer; Betanis/Myrbetriq/BETMIGA, a ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE